SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-166611
Filing Date
2021-05-19
Accepted
2021-05-19 16:13:41
Documents
50
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 6-K d135511d6k.htm 6-K 12591
2 EX-99.1 d135511dex991.htm EX-99.1 205881
3 EX-99.2 d135511dex992.htm EX-99.2 70899
4 EX-99.3 d135511dex993.htm EX-99.3 86453
  Complete submission text file 0001193125-21-166611.txt   2093085

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ncna-20210331.xml EX-101.INS 382626
6 XBRL TAXONOMY EXTENSION SCHEMA ncna-20210331.xsd EX-101.SCH 26934
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ncna-20210331_cal.xml EX-101.CAL 29870
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ncna-20210331_def.xml EX-101.DEF 64231
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ncna-20210331_lab.xml EX-101.LAB 184615
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ncna-20210331_pre.xml EX-101.PRE 145486
Mailing Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT
Business Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT 44-0-131-357-1111
NuCana plc (Filer) CIK: 0001709626 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38215 | Film No.: 21940434
SIC: 2834 Pharmaceutical Preparations